2023 GOLD International COPD Conference
octubre 30, 2023
Join the international educational symposium on Chronic Obstructive Pulmonary Disease (COPD). 2023 marks the 8th Annual GOLD International COPD Conference.
Join the international educational symposium on Chronic Obstructive Pulmonary Disease (COPD). 2023 marks the 8th Annual GOLD International COPD Conference.
The ERS Lung Science Conference: The forefront of basic and translational respiratory science and is an essential event for budding respiratory researchers looking to boost their career. Next 14–17 March, 2024.
Register now for the Caribbean Regional COPD Symposium – Commemorating World COPD Day 2023 «Breathing is Life – Shifting Perspectives on COPD». Next Sunday, October 29, 2023, from 11:30 a.m. (ECT) / 10:30 a.m. (JA).
Our understanding of the pathogenesis of COPD has changed very significantly over the past few years.
Entrevista al Dr. Alvar Agustí en Castilla-La Mancha Despierta para hablar de la importancia diagnóstico temprano de la EPOC.
NOVEDADES GOLD 2024, Reunión mixta el próximo 21 Noviembre 2023, de 17 a 19h. Regístrate cuanto antes (gratuito) en la modalidad Online o Presencial.
Del autor de El emperador de todas las enfermedades, ganador del Premio Pulitzer, y El gen, bestseller número uno del New York Times, llega su libro más espectacular hasta el momento, una exploración de la medicina y nuestra nueva y radical capacidad para manipular las células.
A new research paper was published on the cover of Aging (listed by MEDLINE/PubMed as «Aging (Albany NY)» and «Aging-US» by Web of Science) Volume 15, Issue 14, entitled, «Human senescent fibroblasts trigger progressive lung fibrosis in mice.»
Most patients with chronic obstructive pulmonary disease (COPD) have at least one additional, clinically relevant chronic disease. Those with the most severe airflow obstruction will die from respiratory failure, but most patients with COPD die from non-respiratory disorders, particularly cardiovascular diseases and cancer.
The role of the immune response in the pathogenesis of idiopathic pulmonary fibrosis (IPF) remains controversial.